Upping sustainability in pharma packaging

From glass vials, over cardboard applications, and biodegradable containers, at the PHARMAPACK Europe 2023 taking place on February 1st and 2nd in...

Upscaling AAV gene therapy

Mid-March marks the start of the collaboration of Remedium Bio Inc. and Biovial Oy on an AAV gene therapy for osteoarthritis. Rheumatology and...

BioNTech bags Instadeep for £562m

According to Biontech, the acquisition is part of its strategy to "build world-leading capabilities in AI-driven drug discovery and the...

Evotec and Janssen team up in immunooncology

Hamburg-based Evotec SE has entered into a R&D and licencing agreement with Janssen Biotech, a J&J subsidiary to develop immune-based...

ExeVir receives EIB risk finance for multiple COVID-19 nanobody

With the resurgence of COVID-19 in China, ExeVir BIO sees commercial potential in the future treatment of immunocompromised people, who make up 3%...

Evonetix extends Series B financing to US$54m

According to Evonetix Ltd, a benchtop gene synthesis specialist, the investment, which also includes existing investors such as Molten Ventures,...

High blood pressure reprograms immune system

German scientists headed by Suphansa Sawamiphak from MDC Berlin have discovered in a zebrafish and mouse model of salt-induced hypertension that...